On the other hand, as mentioned above, splicing of certain genes involved in DDR and cell cycle control are selectively vulnerable to splicing factor mutations in MDS and AML [80,81], thus suggesting multiple mechanisms may induce genome instability and drive blood disorders in response to splicing factor mutations. This evidence concerns the gene SLU7 and hematologic disorder.